Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Charles S. Ryan currently holds 200,000 shares of Quince Therapeutics, Inc. (QNCX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles S. Ryan has been a net buyer of QNCX stock. They have purchased $106.5K and sold $0 worth of shares.
Charles S. Ryan's most recent insider trade was on Jan 23, 2026, when they sold 200,000 shares at $0.00 per share.
Charles S. Ryan serves as Executive at Quince Therapeutics, Inc. (QNCX). They have executed 7 insider transactions totaling $106.5K over their tenure at the company.
Charles S. Ryan holds the position of Executive at Quince Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Charles S. Ryan has shown a buying trading pattern, with $106.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Charles S. Ryan was on Mar 1, 2017, when they purchased $80.0K worth of BRTX shares. This transaction involved 26,667 shares at $3.00 per share.
Charles S. Ryan currently owns 200,000 shares of Quince Therapeutics, Inc. (QNCX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Charles S. Ryan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Charles S. Ryan has 7 Form 4 filings on record as an insider at Quince Therapeutics, Inc..
Set alerts for Charles S. Ryan and 40,000+ other insiders.